|
iPSC-based therapeutics have changed preclinical research and iPSC-derived cell types are being utilized to study an array of human conditions, including neurodegenerative diseases. All major brain cell types can now be differentiated from iPSCs, and examining their interactions and impacts on each other is critically important. In addition, iPSC-derived neuronal models can more faithfully recapitulate AD pathologic markers such as Aβ plaques and neurogenic fiber tangles (NFTs), which are rarely observed in 2D cultures.
To advance iPSC technology and iPSC-derived organoids for AD treatment,
ACROBiosystems, through Acro Certify, is pleased to provide you with high-quality matrigengel products for iPSC and organoid culture!
-
Matrigengel Matrix IPSC Level (Acro Certified) (Cat. No. AC-M082777) 1:100 dilution coating the plates, supports stable passage of EPSCs (extended pluripotent stem cells) from P1 to P4.
-
Human tumor organoids, including colorectal cancer organoids, and gastric cancer organoids, are cultured using 70% Matrigengel Matrix Organoid Culture (Acro Certified) (Cat. No. AC-M082755).
| 
